Infection and Immunity, June 1999, p. 2847-2854, Vol. 67, No. 6
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Department of Pathology and Laboratory Medicine1 and Department of Experimental Oncology,2 Medical University of South Carolina, Charleston, South Carolina 29425; Department of Biochemistry, Dartmouth Medical School, Hanover, New Hampshire 037553; and Department of Microbiology and Molecular Genetics, Medical College of Wisconsin, Milwaukee, Wisconsin 532264
Received 7 December 1998/Returned for modification 29 January 1999/Accepted 3 March 1999
| |
ABSTRACT |
|---|
|
|
|---|
Exoenzyme S (ExoS), an ADP-ribosylating enzyme produced by the
opportunistic pathogen Pseudomonas aeruginosa, is directly translocated into eukaryotic cells by bacterial contact. Within the
cell, ExoS ADP-ribosylates the cell signaling protein Ras and causes
inhibition of DNA synthesis and alterations in cytoskeletal structure.
To further understand the interrelationship of the different cellular
effects of ExoS, functional analyses were performed on HT-29 epithelial
cells after exposure to ExoS-producing P. aeruginosa 388 and the non-ExoS-producing strain 388
S. Two different mechanisms of
morphological alteration were identified: (i) a more-transient and
less-severe cell rounding caused by the non-ExoS-producing strain
388
S and (ii) a more-severe, long-term cell rounding caused by
ExoS-producing strain 388. Long-term effects of ExoS on cell morphology
occurred in conjunction with ExoS-mediated inhibition of DNA synthesis
and the ADP-ribosylation of Ras. ExoS was also found to cause
alterations in HT-29 cell function, leading to the loss of cell
adhesion and microvillus effacement. Nonadherent ExoS-treated cells
remained viable but had a high proportion of modified Ras. While
microvillus effacement was detected in both 388- and 388
S-treated
cells, effacement was more prevalent and rapid in cells exposed to
strain 388. We conclude from these studies that ExoS can have multiple
effects on epithelial cell function, with more severe cellular
alterations associated with the enzymatic modification of Ras. The
finding that ExoS had greater effects on cell growth and adherence than
on cell viability suggests that ExoS may contribute to the P. aeruginosa infectious process by rendering cells nonfunctional.
| |
INTRODUCTION |
|---|
|
|
|---|
Pseudomonas aeruginosa is an opportunistic pathogen which affects compromised hosts such as individuals with cystic fibrosis, neutropenia, leukemia, and extensive wounds or burns. A number of proteins produced by P. aeruginosa contribute to its virulence, including exotoxin A, elastase, and phospholipase C, each through characterized mechanisms of action. Less is known about the cellular effects of exoenzyme S (ExoS), an ADP-ribosylating enzyme known to contribute to P. aeruginosa virulence by causing increased tissue damage and bacterial dissemination (14). Difficulties in elucidating the cellular effects of ExoS relate to its type III mechanism of secretion from P. aeruginosa, which requires direct contact between the bacterium and the target cell for the translocation of ExoS (34).
ExoS was first identified in P. aeruginosa 388 culture supernatants as an aggregate of two proteins: 49-kDa ExoS and 53-kDa ExoT (20, 23). These immunologically cross-reactive proteins (14) were subsequently found to be encoded by separate, coregulated genes, with ExoT having 75% amino acid identity with ExoS, but only 0.2% of the catalytic activity (33). The integral relationship between ExoS function and the eukaryotic cell environment was first indicated by the requirement of a eukaryotic cofactor, 14-3-3 proteins, for ExoS ADP-ribosyltransferase (ADPRT) activity (4). In vitro analyses identified multiple, functionally diverse proteins in mammalian cell lysates as substrates for ExoS ADPRT activity. Preferred substrates include specific low-molecular-mass GTP-binding (LMMG) proteins in the Ras superfamily, including Ras (3, 5), and the cytoskeletal protein vimentin (2).
Recognition of the requirement of bacterial contact for the induction
and delivery of ExoS into eukaryotic cells led to the development of
model systems which allowed bacterial translocation of ExoS and yet the
differentiation of the cellular effects of ExoS from those of other
Pseudomonas factors. The model system adapted by our
laboratory used the prototype P. aeruginosa ExoS-producing strain 388 to translocate ExoS, differentiating the effects of ExoS
from those of other strain 388 factors in comparative studies with the
isogenic non-ExoS-producing strain 388
S (25). This system
allowed the identification of inhibitory effects of ExoS production on
DNA synthesis and cellular viability, thus confirming a toxic effect of
ExoS on cell function (25). Later studies with this system
identified Ras as an in vivo substrate of ExoS and found the efficiency
of ADP-ribosylation of Ras to directly correlate with the inhibition of
cellular DNA synthesis, suggesting a cause-and-effect relationship
(22). In a different model system with the
Yersinia type III secretory apparatus to translocate recombinant ExoS, ExoS expression was found to cause disruption of the
actin cytoskeleton (7). In these latter studies, although more severe cell rounding was detected upon the translocation of
wild-type ExoS, cell rounding was also caused by a mutated form of ExoS
having a >2,000-fold-reduced ADPRT activity, thus indicating that
cytoskeletal alterations could occur independently of this enzymatic activity.
The multiple and diverse effects of ExoS on cell function can be explained, to some extent, by its multidomain structure, which includes an amino-terminal domain possessing aggregation properties and required for ExoS secretion and a carboxy-terminal domain having ADPRT enzymatic activity (17, 34). Further diversity in the cellular effects of ExoS may also relate to Ras functioning as an in vivo substrate of ExoS and the potential of Ras to play a pivotal role in multiple signal transduction pathways. The purpose of the studies described here was to further characterize and define the cellular effects of ExoS upon its translocation into human epithelial cells via the P. aeruginosa type III secretory process. The studies identified additional effects of ExoS on cell adherence and microvillus effacement and distinguished two mechanisms by which P. aeruginosa 388 can cause alterations in HT-29 cell morphology: an ExoS-dependent mechanism and an ExoS-independent mechanism. More-severe or long-term effects of ExoS on cell function consistently correlate with the ADP-ribosylation of Ras, suggesting a role of ExoS enzymatic activity in permanent alterations of ExoS in cell function.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Bacterial strains and culture conditions.
P.
aeruginosa strains used in this study include the parental strain
388 (1); strain 388
exoS, which lacks ExoS
production due to an allelic exchange of the majority of the structural
gene with a tetracycline gene cartridge (19); strain
388popD::Tc*, which lacks production of the PopD
translocation protein due to the insertion of the omega cartridge
encoding tetracycline resistance (31); and strain
exs1::Tn1, which has a Tn1
insertion in the pscC type III secretory gene
(34). Strain 388
S complementation studies were performed
by using a two-step cloning strategy to construct a
gentamicin-resistant plasmid containing the exoS structural gene. First, a 1.7-kb PstI/BamHI fragment
containing the exoS structural gene was isolated from
plasmid pUCPexoS (21, 34) by using the
HindIII site within the multiple cloning site of pUCPexoS and the BamHI site downstream of the
exoS structural gene. The 1.7-kb
HindIII/BamHI fragment was then cloned into
the broad-host-range vector pCP13 (6) digested with
HindIII and BamHI. Ligation products were
transformed into Escherichia coli JM109, and the
exoS-containing pCP13 vector (pCP13exoS) was
confirmed by restriction analyses. Second, a 1.6-kb
HindIII fragment containing the gentamicin resistance
cartridge from pGm
1 (29) was cloned into the
HindIII site of pCP13exoS to yield
pCP13exoSGm. Plasmid DNA isolated from gentamicin-resistant
E. coli transformants was confirmed by restriction analyses
and then transformed by triparental mating (12) into strain
388
S. Gentamicin-resistant 388
S clones were selected and
maintained by using 250 to 300 µg of gentamicin per ml.
HT-29 cell culture. HT-29 cells, a human carcinoma cell line obtained from the American Type Culture Collection (ATCC), were cultured as specified by ATCC in McCoy 5A medium supplemented with 10% fetal bovine serum (McCoy-FBS) at 37°C in 5% CO2-95% air. Cells were split 1:6 and passaged as the culture reached confluence. For coculture with bacteria, cells were detached from the growth surface with 0.25% trypsin-1 mM EDTA (trypsin-EDTA) (Gibco-BRL), resuspended in McCoy-FBS, counted, diluted to the appropriate density in McCoy-FBS, and then seeded in 48- or 6-well plates (Costar, Cambridge, Mass.) and cultured for 48 h. Bacteria were cocultured with HT-29 cell monolayers for 1 to 4 h, and HT-29 cells were processed and assayed in cell function assays described below.
Examination of bacterial effects on HT-29 cell function. In all experiments, control and experimental cells were identically treated, except that in controls, coculture medium did not contain bacteria.
(i) Quantification of DNA synthesis. After the coculture period, bacteria were removed from HT-29 cell monolayers; monolayers were then washed with McCoy-FBS containing 200 µg of gentamicin/ml and 100 µg of ciprofloxacin/ml (McCoy-FBS-GC), pulsed in McCoy-FBS-GC, and analyzed for [3H]thymidine incorporation after 20 h, as previously described (25).
(ii) Immunoprecipitation, detection, and quantification of Ras proteins. Ras was immunoprecipitated from cells after coculture with bacteria by using monoclonal Y13-259 Ras antibody (ATCC), rabbit anti-rat immunoglobulin G (Sigma), and protein A-Sepharose (Sigma), as previously described (22). Proteins were resolved on sodium dodecyl sulfate (SDS)-15% polyacrylamide gels, and Ras immunoblots were developed by using pan-Ras OP22 antibody (Oncogene Research, Cambridge, Mass.) and enhanced chemiluminescence (Amersham).
(iii) Examination of cell morphology. Long-term effects of strain 388 and mutant strains on cell morphology were assessed by phase-contrast microscopy in conjunction with DNA synthesis assays at the end of the 20-h pulse period. For video time-lapse microscopy, cells were grown and cultured with bacteria in 25-cm2 flasks. After the removal of bacteria and the addition of medium containing antibiotics, culture vessels were placed in an incubation chamber mounted on the stage of an adapted Zeiss ICM-405 inverted phase-contrast microscope. The temperature in the chamber was maintained at 37°C, and the atmosphere contained 5% CO2-95% air. Selected fields of ca. 100 cells were examined by using a 40× objective lens, and images were captured by using a Hitachi KP-M1U charge-coupled device camera. Recordings were made at a temporal ratio of 20:1 by using a time-lapse video recorder.
(iv) Analysis of cellular adherence. After a 3-h coculture period, bacteria were removed, HT-29 cell monolayers were washed three times with McCoy-FBS-GC, and then cells were detached from the growth surface with trypsin-EDTA. Detached cells were resuspended in the original volume of McCoy-FBS-GC, replated, and allowed to grow for 20 h. At this time, nonadherent cells were recovered and saved and adherent cells were detached with trypsin-EDTA. Each cell population was assayed for cell number, viability, and necrosis by trypan blue exclusion, as previously described (25), and for DNA synthesis, Ras modification, and apoptosis.
(v) Analysis of apoptosis. To quantify internucleosomal fragmentation, 106 HT-29 cells, treated as indicated, were lysed, and DNA fragmentation was analyzed in a Cell Death Detection enzyme-linked immunosorbent assay (ELISA; Boehringer Mannheim, Indianapolis, Ind.). The relative amount of apoptosis was determined by calculating an enrichment factor in which the absorbance of the sample (after subtracting the background level) was divided by the absorbance of the control.
Scanning electron microscopy.
Bacterial strains 388, 388
S,
PopD, and
PscC (108 CFU/ml) or no bacteria
were cultured for 1, 2, or 3 h with HT-29 cell monolayers grown on
12-mm glass coverslips. Bacteria were removed, and cells were washed
twice with McCoy-BSA, fixed in situ in 2% glutaraldehyde in 0.1 M
cacodylate buffer (pH 7.4), rinsed, postfixed in 1% osmium in 0.1 M
cacodylate buffer, and then dehydrated in a graded series of ethanol
mixtures and treated with hexamethyldisilane. After they were dried,
coverslips were coated with gold and examined by using a JEOL
JSEM-LV5410 scanning electron microscope.
| |
RESULTS |
|---|
|
|
|---|
Identification of ExoS-specific effects on HT-29 cell DNA synthesis
and morphology.
Identifying the effects of ExoS on cell function
has been complicated by its type III mechanism of secretion and the
requirement for bacterial contact in the delivery of ExoS into target
cells. To differentiate the cellular effects of ExoS from those of
other bacterial factors during coculture studies, P. aeruginosa strains having mutations in ExoS production or
components of the type III secretory process were compared for their
effects on DNA synthesis and cellular morphology. The specific strains
examined included the following: (i) ExoS-producing strain 388; (ii)
the non-ExoS-producing isogenic strain 388
S; (iii) strain 388
S
complemented with a pCP13exoSGm plasmid containing the
exoS structural gene (
S+S); (iv) strain
388popD::Tc*, which lacks expression of PopD, a
homolog of Yersinia YopD involved in type III translocation
(
PopD) (36); and (v) strain 388 exs1::Tn1, which lacks production of
PscC, a homolog of the Yersinia YscC protein involved in
type III secretion (
PscC) (34). The differential effect
of each of the 388 strains on HT-29 epithelial cell function was
examined relative to the induction or noninduction of ExoS production
prior to the coculture period. High levels of ExoS production were
confirmed in culture supernatants of strains 388 and
S+S grown in
TSBD-N inducing medium prior to coculture with HT-29 cells (46.6 and
36.9 fmol of ADP-ribose transferred min
1
ml
1, respectively), but not in the respective strains
grown in TSB noninducing medium (<0.3 fmol of ADP-ribose transferred
min
1 ml
1). Regardless of the bacterial
preculture conditions, the same pattern of DNA synthesis inhibition by
the bacterial strains was detected, indicating that contact with HT-29
cells is sufficient for the induction of ExoS effects on DNA synthesis
(Fig. 1). Strains 388 and
S+S were
found to cause the greatest (and comparable) levels of inhibition of
[3H]thymidine incorporation (~80%), which correlated
with an equally efficient shift in Ras mobility (Fig. 1, inset). Less
inhibition of DNA synthesis was caused by strains 388
S,
PopD, and
PscC (~50%), the comparable inhibition by these mutants
reflecting an undefined bacterial factor not related to ExoS production
nor the expression of the respective type III secretory products. The
30% greater inhibition of DNA synthesis and the modification of Ras by
strains 388 and
S+S, when compared to that of 388
S, identifies an
ExoS-specific effect. The lack of this 30% greater inhibition in the
type III secretory mutants also confirms the requirement of the
P. aeruginosa PopD translocation and PscC secretion proteins
for ExoS effects on DNA synthesis. When HT-29 cell morphological alterations were examined 20 h after exposure to bacteria, at the
end of the DNA pulse period, severe rounding was detected in HT-29
cells exposed to strains 388 and
S+S but not in HT-29 cells exposed
to the other bacterial strains (Fig. 2).
We conclude from these studies that ExoS production by strain 388 is
directly associated with increased inhibition of DNA synthesis, Ras
modification, and long-term alterations in cell morphology.
|
|
Examination of the temporal course of morphological changes in
HT-29 cells caused by strain 388.
Further understanding of the
effects of ExoS on HT-29 cell morphology was gained by using time-lapse
microscopy. In these studies, HT-29 cells were cocultured with strain
388 or 388
S for 3 h, and then bacteria were removed and the
cells were treated with antibiotics to inhibit further bacterial growth
and monitored for morphological alterations over a 24-h period. Cell
rounding was evident 3 h after exposure to both strains 388 and
388
S compared to non-bacterium-treated control cells, but the
rounding caused by strain 388 was more severe (Fig.
3). The differential effects of strains
388 and 388
S on cell morphology became more evident after 24 h,
at which time cells exposed to strain 388
S regained normal
morphology, while those exposed to strain 388 remained rounded. These
studies draw attention to different mechanisms by which strain 388 can
cause morphological alterations. One mechanism, which appears less
severe and more transient, is recognized in strain 388
S and occurs
in the absence of enzymatically active ExoS. A second, which causes a
long-term alteration in cellular morphology, occurs in the presence of
enzymatically active ExoS.
|
Effects of ExoS production on cell adherence.
Functional
consequences of differential effects of strains 388 and 388
S on
cellular morphology were examined by using cell re-adherence assays.
Since minimal loss of HT-29 cell adherence to cell matrix was observed
in association with cell rounding after the 3-h coculture period with
either strain 388 or strain 388
S, adherence was functionally
evaluated in replating assays where HT-29 cells were passaged after a
3-h exposure to bacteria. Cell viability and the efficiency of
re-adherence were then examined 20 h later. As shown in Fig.
4, more than 95% of HT-29 cells exposed to strain 388
S were able to re-adhere at 20 h. This compared to
only 27% of the 388-treated cells being able to re-adhere, with 65%
of the 388-treated cells remaining viable but nonadherent. DNA
synthesis assays detected the relative rate of
[3H]thymidine incorporation in cells exposed to strain
388 to be approximately twofold lower than in cells exposed to strain
388
S, regardless of the re-adherence. When the eventual fate of the 388-treated cells was assessed, the number of necrotic cells was two-
to threefold higher after treatment with strain 388 compared to
treatment with strain 388
S or with no bacteria, averaging 13.2 ± 3.6% at 24 h and 26.4 ± 6.6% at 48 h. A similar
relative increase in the number of apoptotic cells was detected in
388-treated cells with an ELISA to quantify nucleosomal DNA fragments
present in the cell lysates. Levels of apoptosis in cells exposed to
strains 388 and 388
S were increased by factors of 7.4 ± 1.1 and 2.6 ± 1.1, respectively, compared to non-bacterium-treated
control cells. A DNA ladder, characteristic of apoptosis, was detected
in HT-29 cells exposed to strain 388 but not in cells exposed to strain 388
S or to no bacteria (not shown). While we cannot determine from
our studies whether the observed decrease in cell viability after
exposure to strain 388 was due to loss of adherence or a direct effect
of ExoS, recent studies have found the ADPRT domain of ExoS to be
cytotoxic when transiently expressed in CHO and Vero cells
(26), implying that both mechanisms are possible. The
finding, however, that cell viability was maintained in a high
percentage of 388-treated cells 20 h after exposure to bacteria indicates that the immediate effect of ExoS on HT-29 cells was not on
viability but on cell morphology, adherence, and DNA synthesis.
|
|
Examination of HT-29 cellular alterations associated with ExoS
production and type III secretory processes.
Scanning electron
microscopy was used to compare the progression of cellular changes
after a 1-, 2-, or 3-h exposure of HT-29 cells to strains 388, 388
S,
PopD, and
PscC. As shown in Fig. 6A and
B, cell rounding was evident in HT-29
cells after a 1- or 3-h exposure to strain 388 and, in many instances,
rounded cells showed a severe loss of cell surface microvilli. Bacteria appeared to remain securely attached to HT-29 cells in the absence of
microvilli, and no cellular structures, such as pedestals, were evident
underneath the bacteria. While cell rounding and loss of microvilli
were also apparent in cells exposed to strain 388
S, both events
occurred more slowly, with loss of microvilli detected only after
3 h and three- to fourfold less frequently than was observed with
strain 388. Cell rounding was also detected in HT-29 cells after
coculture with strains
PopD and
PscC; however, no notable loss of
microvilli was observed during the 3-h exposure to bacteria. The
finding that ExoS facilitates but is not required for cell rounding or
effacement draws attention to the ability of non-ExoS-related bacterial
factors to initiate alterations in cell structure and loss of
microvilli. The inability of PopD and PscC mutant strains to cause
effacement within the same time frame also implies the role of the type
III secretory process in cellular alterations leading to the loss of
HT-29 cell surface microvilli.
|
| |
DISCUSSION |
|---|
|
|
|---|
As an understanding of ExoS and its regulatory and secretory processes unfolds, it becomes increasingly evident that ExoS functions in a manner distinctly different from other known P. aeruginosa virulence factors. ExoS is part of a complex regulon that includes a type III secretory process and responds to eukaryotic cell contact. The contact-mediated translocation of ExoS into target cells, as with other type III secreted proteins, allows ExoS direct access to eukaryotic cell signaling processes. Current data support that ExoS can have multiple effects on cell function, which likely relates to independent, but coordinated, activities of the amino- and carboxy-terminal domains of ExoS, as well as to its enzymatic modification of cellular Ras, a protein integral to cell signaling through multiple pathways.
To gain a more precise understanding of the interrelationship of cellular processes involved in the effects of ExoS on cell function, the differential effects of the ExoS-producing strain 388 on HT-29 epithelial cell function were compared to those of 388 mutant strains lacking production of ExoS or defined components of the type III secretory system. A 30% greater inhibition of DNA synthesis was identified as being a direct result of the production and type III-mediated translocation of ExoS. This occurred in addition to an approximate 50% inhibition of HT-29 cell DNA synthesis caused by non-ExoS- or non-type III-related bacterial factors produced by strain 388 during the coculture period. While the bacterial factors responsible for the non-ExoS-related inhibition have not been specifically investigated, this inhibition appears to differ from that of ExoS in becoming more pronounced upon prolonged exposure to bacteria. Previous studies found the differential effects of ExoS production on DNA synthesis to be initiated relatively early in the coculture period, detectable after a 0.5-h exposure to bacteria, but becoming optimal within a 3- to 4-h exposure (22, 25). Other, more generalized effects on cell function, including inhibition of protein synthesis, decreased cell viability, as well as increased inhibition of DNA synthesis, become apparent upon prolonged coculture times or exposure to higher concentrations of bacteria. The complex and multiple effects of strain 388 on cell function reflect the multifactorial nature of P. aeruginosa virulence. The effects of ExoS on Ras modification and DNA synthesis, however, appear to precede other effects on cell function, implying a role in early stages of the P. aeruginosa infectious process.
Consistent with common or coordinated signaling events being involved
in the effects of ExoS on DNA synthesis and cytoskeletal alterations,
both events were initiated early in the coculture period, required an
intact type III secretory apparatus, and were associated with the
ADP-ribosylation of Ras. Time-lapse video studies revealed that strain
388 could cause alterations in cell morphology by an ExoS-independent
mechanism, as well as by an ExoS-dependent mechanism. Long-term
alterations in cell morphology required ExoS production, while
short-term alterations in morphology were apparent in strain
388
S-treated HT-29 cells, and both appeared to be facilitated by an
intact type III secretory process. Strain 388
S produces two known
type III effector proteins, ExoT and ExoY, both of which have been
found to cause cell rounding (30, 37). It is notable that
the less severe, short-term cell rounding detected in HT-29 cells
cocultured with strain 388
S resembled that of the less severe cell
rounding observed by Frithz-Lindsten et al. (7) when the
effects of wild-type ExoS and of the E381A enzymatic mutant form of
ExoS on HeLa cells were compared. Although the effects of an ADPRT
inactive form of ExoS were not directly examined in our studies, strain
388
S produces ExoT, which is highly homologous to ExoS, yet it has
<0.2% of the catalytic activity. Thus, it is possible that ExoT,
produced by strain 388
S, may be functioning in a manner similar to
that of E381A mutant ExoS in causing the less-severe, short-term cell
rounding. The amino-terminal domain of ExoS shows homology with the
Yersinia virulence factor YopE (35), a
Yersinia cytotoxin that disrupts cytoskeletal structure by
an as-yet-undefined mechanism (28). Similarly, the
amino-terminal domain of SptP, a virulence factor secreted by
Salmonella typhimurium via the type III process, has been
found to share homology with YopE and ExoS and cause a similar
disruption of actin cytoskeleton structure (8). The
seemingly comparable alteration in cell morphology caused by type III
effector proteins, independent of other identified enzymatic
activities, suggests that a transient alteration in host cytoskeletal
structure may be a common feature of proteins translocated by the type
III secretory process.
Functional consequences of differences in the effects of strains 388 and 388
S on HT-29 cell morphology became more evident in cellular
adherence analyses. Although neither strain 388 nor strain 388
S
caused significant loss of HT-29 cell adherence during the coculture
period, when cells were passaged after exposure to bacteria and assayed
for re-adherence, less than one-third of strain 388-treated cells were
able to re-adhere to tissue culture wells. The ADP-ribosylation of Ras
by ExoS appeared to precede and increase with the loss of re-adherence,
suggesting coordination between loss of adherence and Ras modification.
These studies indicate that long-term alterations in cell morphology
caused by strain 388 can be functionally differentiated from the
short-term alterations of strain 388
S, based on their association
with the disruption of focal adhesion. Focal adhesion complexes play an integral role in the transduction of cellular signals, and the formation of stable focal adhesion complexes are linked to the actin
cytoskeletal structure (38). The effects of ExoS on cell adherence and cytoskeletal structure could therefore both be linked to
an interruption of actin polymerization. The previous finding that ExoS
can exert less-severe effects on cell morphology in an
ADPRT-independent manner (7), coupled with our observation that more-severe cytoskeletal alterations and loss of cell matrix adherence occur in association with Ras modification, is consistent with the multifunctional domain structure of ExoS, with the
amino-terminal YopE homologous region of ExoS causing transient
alterations in cytoskeletal structure that are coordinated with
more-severe cytoskeletal alterations caused by the ADP-ribosylation of
cellular proteins by the carboxy-terminal domain.
In previous studies, the modification of Ras by ExoS was found to correlate directly with inhibition of DNA synthesis (22). Although a large number of Ras-effector interactions have been identified (16), the best characterized of these, the activation of Raf by interaction with Ras, induces the transfer of a proliferative or differentiation signal to the nucleus. Recent in vitro and in vivo studies have found that the ADP-ribosylation of Ras by ExoS interferes with Raf activation (10, 32), thus providing a mechanism for the inhibitory effects of ExoS on DNA synthesis and PC12 neurite outgrowth (9, 25). A current understanding of cell signaling pathways finds that Ras can also affect cytoskeletal structure through indirect interactions with the Rho subfamily of LMMG proteins that regulate actin polymerization. Rho, Rac, and Cdc42 play distinct roles in actin rearrangement, forming stress fibers, lamellipodia, and filopodia, respectively. These three proteins also form an interactive network, with Cdc42 able to activate Rac, and Rac able to activate Rho, and all three can associate with integrin-based adhesion complexes (reviewed in references 11 and 13). Ras, via its direct interaction with phophatidylinositol 3-kinase (PI3K), can activate Rac and cause actin rearrangement (27). The guanine nucleotide exchange factor Sos has also been found to couple Ras with Rac in a PI3K-dependent manner (24). Thus, it is possible that effects of ExoS on cytoskeletal structure may result from the modification of Ras. An alternative explanation for the cytoskeletal effects of ExoS relates to the potential diverse substrate specificity of ExoS and the possibility that ExoS might directly modify or alter the function of proteins, such as Rac, Cdc42, Rho, or the intermediate filament vimentin, that affect cytoskeletal structure. Effects of ExoS on cell morphology and adherence would thus appear to be coordinated with Ras modification and the inhibition of DNA synthesis but mediated by the modification of proteins in alternative signal transduction pathways.
While many similarities are observed in eukaryotic cell functions
altered by the type III secretory process of different bacteria, each
bacterium appears to manipulate eukaryotic pathways in a slightly
different manner which best enhances the survival of the specific
organism. P. aeruginosa, like enteropathogenic E. coli (EPEC), is predominantly an extracellular organism, and both bacteria use type III secreted proteins to mediate their infectious processes. Electron microscopy studies revealed that contact between EPEC and host epithelial cells results in the effacement of microvilli from the surface of cells and the production of a densely packed cytoskeletal structure forming a pedestal beneath the bacterium (18). Microvilli effacement and pedestal formation were
found to be associated with the accumulation of cellular actin and to require the EPEC type III secretory system (15). When the
interaction of the ExoS-producing strain 388 with HT-29 cells was
examined by scanning electron microscopy, microvillus effacement,
similar to that observed for EPEC, was detected, often in conjunction with severe cell rounding. No pedestal-like structures, however, were
evident underneath strain 388 P. aeruginosa. Some
microvillus effacement was also apparent in HT-29 cells exposed to
strain 388
S, indicating that the process can occur independently of ExoS production; however, effacement was facilitated by ExoS
production. Scanning electron microscopy revealed minimal loss of
microvilli in HT-29 cells treated with strain 388 bacteria having
mutations in their type III secretory apparatus, indicating, as with
EPEC, that the type III secretory system facilitates the P. aeruginosa effacement process. Thus, like other bacteria whose
infectious process is mediated by the type III secretory system,
P. aeruginosa appears to have acquired a slightly different
mechanism of manipulating eukaryotic cell function, but alterations in
actin cytoskeletal structure appear to be part of this mechanism.
The studies described here have increased the list of effects that ExoS can have on cell function, providing further insight into the complex effects of ExoS on eukaryotic cell signaling processes. Although the coordinated activities of both enzymatic and nonenzymatic portions of ExoS cause alterations in cell function, the direct association of the ADP-ribosylation of Ras with effects of ExoS on DNA synthesis, cell adherence, and long-term morphological alterations are consistent with ExoS ADPRT activity contributing to the more-severe alterations in cell function. While different signaling pathways may be involved in these cellular effects, a common signal leading to an interruption of cell function appears to be delivered to HT-29 epithelial cells. This becomes most apparent in functional analyses of HT-29 cell populations that lose adherence after exposure to ExoS-producing bacteria. These cells have a lower DNA proliferative index, lack functional focal adhesion complexes and cytoskeletal structures required for the integration of cell signals, and have a high proportion of ADP-ribosylated Ras, and yet the majority of cells remain viable after 48 h. This indicates that the immediate outcome of exposure to ExoS is not cell death but rather an inhibition of normal cellular processes required for growth and adherence. While the effects of ExoS on cell viability can be observed upon more-prolonged exposure to bacteria (25), we hypothesize that the initial role of ExoS in the P. aeruginosa infectious process is one of cellular inactivation. ExoS production, in combination with other P. aeruginosa virulence factors, then leads to the eventual death of the target cell via necrotic and apoptotic mechanisms. Relative to epithelial tissue, an interruption of cell growth and adherence would result in increased bacterial dissemination.
| |
ACKNOWLEDGMENTS |
|---|
We thank Dennis Ohman for his help in the construction of the
pCP13exoSGm plasmid used in the 388
S complementation
studies. We also thank Debra Hazen-Martin and Carol Moskos for their
assistance in the scanning electron microscopy studies and Lisa Rucks
for her assistance in the coculture studies.
This work was supported by NIH grant AI41694.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Medical University of South Carolina, Department of Pathology and Laboratory Medicine, 165 Ashley Ave., Charleston, SC 29425. Phone: (843) 792-7761. Fax: (843) 792-4157. E-mail: olsonj{at}musc.edu.
Editor: D. L. Burns
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Bjorn, M. J.,
O. R. Pavlovskis,
M. R. Thompson, and B. H. Iglewski.
1979.
Production of exoenzyme S during Pseudomonas aeruginosa infections of burned mice.
Infect. Immun.
24:837-842 |
| 2. |
Coburn, J.,
S. T. Dillon,
B. H. Iglewski, and D. M. Gill.
1989.
Exoenzyme S of Pseudomonas aeruginosa ADP-ribosylates the intermediate filament protein vimentin.
Infect. Immun.
57:996-998 |
| 3. |
Coburn, J., and D. M. Gill.
1991.
ADP-ribosylation of p21ras and related proteins by Pseudomonas aeruginosa exoenzyme S.
Infect. Immun.
59:4259-4262 |
| 4. |
Coburn, J.,
A. V. Kane,
L. Feig, and D. M. Gill.
1991.
Pseudomonas aeruginosa exoenzyme S requires a eukaryotic protein for ADP-ribosyltransferase activity.
J. Biol. Chem.
266:6438-6446 |
| 5. |
Coburn, J.,
R. T. Wyatt,
B. H. Iglewski, and D. M. Gill.
1989.
Several GTP-binding proteins, including p21c-H-ras, are preferred substrates of Pseudomonas aeruginosa exoenzyme S.
J. Biol. Chem.
264:9004-9008 |
| 6. |
Darzins, A., and A. M. Chakrabarty.
1984.
Cloning of genes controlling alginate biosynthesis from a mucoid cystic fibrosis isolate of Pseudomonas aeruginosa.
J. Bacteriol.
159:9-18 |
| 7. | Frithz-Lindsten, E., Y. Du, R. Rosqvist, and A. Forsberg. 1997. Intracellular targeting of exoenzyme S of Pseudomonas aeruginosa via type III dependent translocation induces phagocytosis resistance, cytotoxicity and disruption of actin microfilaments. Mol. Microbiol. 25:1125-1139[Medline]. |
| 8. | Fu, Y., and J. E. Galan. 1998. The Salmonella typhimurium tyrosine phosphatase SptP is translocated into host cells and disrupts the actin cytoskeleton. Mol. Microbiol. 27:359-368[Medline]. |
| 9. |
Ganesan, A. K.,
D. W. Frank,
R. P. Misra,
G. Schmidt, and J. T. Barbieri.
1998.
Pseudomonas aeruginosa exoenzyme S ADP-ribosylates Ras at multiple sites.
J. Biol. Chem.
273:7332-7337 |
| 10. | Ganesan, A. K., T. S. Vincent, J. C. Olson, and J. T. Barbieri. Pseudomonas aeruginosa exoenzyme S disrupts Ras-mediated signal transduction by inhibiting guanine nucleotide exchange factor catalyzed nucleotide exchange. Submitted for publication. |
| 11. | Giancotti, F. G. 1997. Integrin signaling: specificity and control of cell survival and cell cycle progression. Curr. Opin. Cell Biol. 9:691-700[Medline]. |
| 12. |
Goldberg, J. B., and D. E. Ohman.
1984.
Cloning and expression in Pseudomonas aeruginosa of a gene involved in the production of alginate.
J. Bacteriol.
158:1115-1121 |
| 13. |
Hall, A.
1998.
Rho GTPases and the actin cytoskeleton.
Science
279:509-514 |
| 14. | Iglewski, B. H. 1988. Pseudomonas toxins, p. 249-265. In M. C. Hardegree, and A. T. Tu (ed.), Handbook of toxins, vol. 4. Marcel Dekker, New York, N.Y. |
| 15. |
Jarvis, K. G.,
J. A. Giron,
A. E. Jerse,
T. K. McDaniel,
M. S. Donnenberg, and J. B. Kaper.
1995.
Enteropathogenic Escherichia coli contains a putative type III secretion system necessary for the export of proteins involved in attaching and effacing lesion formation.
Proc. Natl. Acad. Sci. USA
92:7996-8000 |
| 16. | Katz, M. E., and F. McCormick. 1997. Signal transduction from multiple Ras effectors. Curr. Opin. Genet. Dev. 7:75-79[Medline]. |
| 17. | Knight, D. A., V. Finck-Barbancon, S. M. Kulich, and J. T. Barbieri. 1995. Functional domains of Pseudomonas aeruginosa exoenzyme S. Infect. Immun. 63:3182-3186[Abstract]. |
| 18. |
Knutton, S.,
T. Baldwin,
P. H. Williams, and A. S. McNeish.
1989.
Actin accumulation at sites of bacterial adhesion to tissue culture cells: basis of a new diagnostic test for enteropathogenic and enterohemorrhagic Escherichia coli.
Infect. Immun.
57:1290-1298 |
| 19. | Kulich, S. M., D. W. Frank, and J. T. Barbieri. 1995. Expression of recombinant exoenzyme S of Pseudomonas aeruginosa. Infect. Immun. 63:1-8[Abstract]. |
| 20. | Kulich, S. M., D. W. Frank, and J. T. Barbieri. 1993. Purification and characterization of exoenzyme S from Pseudomonas aeruginosa 388. Infect. Immun. 61:307-313. |
| 21. |
Kulich, S. M.,
T. L. Yahr,
L. M. Mende-Mueller,
J. T. Barbieri, and D. W. Frank.
1994.
Cloning the structural gene for the 49-kDa form of exoenzyme S (exoS) from Pseudomonas aeruginosa strain 388.
J. Biol. Chem.
269:10431-10437 |
| 22. |
McGuffie, E. M.,
D. W. Frank,
T. S. Vincent, and J. C. Olson.
1998.
Modification of Ras in eukaryotic cells by Pseudomonas aeruginosa exoenzyme S.
Infect. Immun.
66:2607-2613 |
| 23. |
Nicas, T. I., and B. H. Iglewski.
1984.
Isolation and characterization of transposon-induced mutants of Pseudomonas aeruginosa deficient in production of exoenzyme S.
Infect. Immun.
45:470-474 |
| 24. |
Nimnual, A. S.,
B. A. Yatsula, and D. Bar-Sagi.
1998.
Coupling of Ras and Rac guanosine triphosphatases through the Ras exchanger Sos.
Science
279:560-563 |
| 25. | Olson, J. C., E. M. McGuffie, and D. W. Frank. 1997. Effects of differential expression of the 49-kilodalton exoenzyme S by Pseudomonas aeruginosa on cultured eukaryotic cells. Infect. Immun. 65:248-256[Abstract]. |
| 26. | Pederson, K. J., and J. T. Barbieri. 1998. Intracellular expression of the ADP-ribosyltransferase domain of Pseudomonas exoenzyme S is cytotoxic to eukaryotic cells. Mol. Microbiol. 30:751-759[Medline]. |
| 27. | Rodriguez-Viciana, P., P. H. Warne, A. Khwaja, B. M. Marte, D. Pappin, P. Das, M. D. Waterfield, A. Ridley, and J. Downward. 1997. Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell 89:457-467[Medline]. |
| 28. |
Rosqvist, R.,
A. Forsberg, and H. Wolf-Watz.
1991.
Intracellular targeting of the Yersinia YopE cytotoxin in mammalian cells induces actin microfilament disruption.
Infect. Immun.
59:4562-4569 |
| 29. | Schweizer, H. P. 1993. Small broad-host range gentamicin cassettes for site-specific insertion and deletion mutagenesis. BioTechniques 15:831-833[Medline]. |
| 30. |
Vallis, A. J.,
V. Finck-Barbancon,
T. L. Yahr, and D. W. Frank.
1998.
Biological effects of Pseudomonas type III-secreted proteins on CHO cells.
Infect. Immun.
67:2040-2044 |
| 31. |
Vallis, A. J.,
T. L. Yahr,
J. T. Barbieri, and D. W. Frank.
1999.
Regulation of ExoS production and secretion by Pseudomonas aeruginosa in response to tissue culture conditions.
Infect. Immun.
67:914-920 |
| 32. | Vincent, T. S., J. E. Fraylick, E. M. McGuffie, and J. C. Olson. ADP-ribosylation of oncogenic Ras proteins by Pseudomonas aeruginosa exoenzyme S in vivo. Mol. Microbiol., in press. |
| 33. |
Yahr, T. L.,
J. T. Barbieri, and D. W. Frank.
1996.
Genetic relationship between the 53- and 49-kilodalton forms of exoenzyme S from Pseudomonas aeruginosa.
J. Bacteriol.
178:1412-1419 |
| 34. | Yahr, T. L., J. Goranson, and D. W. Frank. 1996. Exoenzyme S of Pseudomonas aeruginosa is secreted by a type III pathway. Mol. Microbiol. 22:991-1003[Medline]. |
| 35. |
Yahr, T. L.,
A. K. Hovey,
S. M. Kulich, and D. W. Frank.
1995.
Transcriptional analysis of the Pseudomonas aeruginosa exoenzyme S structural gene.
J. Bacteriol.
177:1169-1178 |
| 36. |
Yahr, T. L.,
L. M. Mende-Mueller,
M. B. Friese, and D. W. Frank.
1997.
Identification of type III secreted products of the Pseudomonas aeruginosa exoenzyme S regulon.
J. Bacteriol.
179:7165-7168 |
| 37. |
Yahr, T. L.,
A. J. Vallis,
M. K. Hancock,
J. T. Barbieri, and D. W. Frank.
1998.
ExoY, an adenylate cyclase secreted by Pseudomonas aeruginosa type III system.
Proc. Natl. Acad. Sci. USA
95:13899-13904 |
| 38. | Yamada, K. M., and B. Geiger. 1997. Molecular interactions in cell adhesion complexes. Curr. Opin. Cell Biol. 9:76-85[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|